Page 3 - Diagnostic Network News Today

Investegate announcements from Diaceutics PLC, Presenting data on COVID impact on cancer at ASCO

PARSIPPANY, N.J.--(BUSINESS WIRE)--Diaceutics PLC, the diagnostic commercialisation company, today announces the acceptance of an abstract for a poster discussion presentation, discussing the impact of COVID-19 on cancer diagnosis, at the prestigious 2021 American Society of Clinical Oncology (ASCO) Annual Meeting,...

Investegate announcements from Diaceutics PLC, Sale of Shares and PDMR Shareholding

About Diaceutics At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the worlds first Diagnostic Network solution for the development and commercialisation of precision medicine diagnostics. The Group, listed on the AIM Market of the London Stock Exchange, has created commercially useful data sets for every precision medicine that has come to market. We have built the w...

Anna Dunphy  Paul McManus    About Diaceutics At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - our Proprietary Diagnostic Network solution for the development and commercialisation of precision medicine diagnostics. The Company, listed on the AIM Market of the London Stock Exchange, has created commercially useful data sets for every precision medicine that has come to market...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

12/22/20 PARSIPPANY, NJ--(BUSINESS WIRE)--Diaceutics PLC, (AIM: DXRX), today announces the appointment of Deborah Davis as Non-Executive Chair, effective from 4 January 2021. Davis brings extensive global experience in software, fintech, telecoms, e-commerce and platform-based businesses. After completing her undergraduate studies in Australia, Deborah spent 25 years in CEO and executive roles including 14 years in European and global senior leadership roles at internet platform businesses Pay...

Press release content from Business Wire. The AP news staff was not involved in its creation. Diaceutics Appoints Seasoned Business Leader Deborah Davis as Non-executive Chair December 22, 2020 GMT Newly appointed Diaceutics Non-Executive Chair, Deborah Davis. (Photo: Business Wire) PARSIPPANY, NJ--(BUSINESS WIRE)--Dec 22, 2020-- Diaceutics PLC, (AIM: DXRX), today announces the appointment of Deborah Davis as Non-Executive Chair, effective from 4 January 2021. Davis brings extensive global expe...